Live mucosal vaccination stimulates potent protection via varied CD4+ and CD8+ T cell subsets against wild-type Brucella melitensis 16M challenge

Re-emerging zoonotic pathogen Brucella spp. continues to impact developing countries and persists in expanding populations of wildlife species in the US, constantly threatening infection of our domestic herds. The development of improved animal and human vaccines remains a priority. In this study, i...

Full description

Bibliographic Details
Main Authors: Zakia I. Goodwin, Xinghong Yang, Carol Hoffman, David W. Pascual
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.995327/full
_version_ 1811238619316224000
author Zakia I. Goodwin
Xinghong Yang
Carol Hoffman
David W. Pascual
author_facet Zakia I. Goodwin
Xinghong Yang
Carol Hoffman
David W. Pascual
author_sort Zakia I. Goodwin
collection DOAJ
description Re-emerging zoonotic pathogen Brucella spp. continues to impact developing countries and persists in expanding populations of wildlife species in the US, constantly threatening infection of our domestic herds. The development of improved animal and human vaccines remains a priority. In this study, immunity to a novel live attenuated B. melitensis strain, termed znBM-mC, was characterized. An oral prime, intranasal (IN) boost strategy conferred exquisite protection against pulmonary challenge, with wild-type (wt) B. melitensis providing nearly complete protection in the lungs and spleens from brucellae colonization. Vaccination with znBM-mC showed an IFN-γ+ CD8+ T-cell bias in the lungs as opposed to Rev 1-vaccinated mice showing IFN-γ+ CD4+ T-cell inclination. Lung CD4+ and CD8+ effector memory T cells (TEMs) increased over 200-fold; and lung CD4+ and CD8+ resident memory T cells (TRMs) increased more than 250- and 150-fold, respectively. These T cells served as the primary producers of IFN-γ in the lungs, which was essential for vaccine clearance and the predominant cytokine generated pre-and post-challenge with wt B. melitensis 16M; znBM-mC growth could not be arrested in IFN-γ−/− mice. Increases in lung TNF-α and IL-17 were also induced, with IL-17 being mostly derived from CD4+ T cells. Vaccination of CD4−/−, CD8−/−, and B6 mice with znBM-mC conferred full protection in the lungs and spleens post-pulmonary challenge with virulent B. melitensis; vaccination of IL-17−/− mice resulted in the protection of the lungs, but not the spleen. These data demonstrate the efficacy of mucosal vaccine administration for the generation of protective memory T cells against wt B. melitensis.
first_indexed 2024-04-12T12:44:40Z
format Article
id doaj.art-1dc1b66c286c4b6584653433548f493b
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T12:44:40Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-1dc1b66c286c4b6584653433548f493b2022-12-22T03:32:38ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-10-011310.3389/fimmu.2022.995327995327Live mucosal vaccination stimulates potent protection via varied CD4+ and CD8+ T cell subsets against wild-type Brucella melitensis 16M challengeZakia I. GoodwinXinghong YangCarol HoffmanDavid W. PascualRe-emerging zoonotic pathogen Brucella spp. continues to impact developing countries and persists in expanding populations of wildlife species in the US, constantly threatening infection of our domestic herds. The development of improved animal and human vaccines remains a priority. In this study, immunity to a novel live attenuated B. melitensis strain, termed znBM-mC, was characterized. An oral prime, intranasal (IN) boost strategy conferred exquisite protection against pulmonary challenge, with wild-type (wt) B. melitensis providing nearly complete protection in the lungs and spleens from brucellae colonization. Vaccination with znBM-mC showed an IFN-γ+ CD8+ T-cell bias in the lungs as opposed to Rev 1-vaccinated mice showing IFN-γ+ CD4+ T-cell inclination. Lung CD4+ and CD8+ effector memory T cells (TEMs) increased over 200-fold; and lung CD4+ and CD8+ resident memory T cells (TRMs) increased more than 250- and 150-fold, respectively. These T cells served as the primary producers of IFN-γ in the lungs, which was essential for vaccine clearance and the predominant cytokine generated pre-and post-challenge with wt B. melitensis 16M; znBM-mC growth could not be arrested in IFN-γ−/− mice. Increases in lung TNF-α and IL-17 were also induced, with IL-17 being mostly derived from CD4+ T cells. Vaccination of CD4−/−, CD8−/−, and B6 mice with znBM-mC conferred full protection in the lungs and spleens post-pulmonary challenge with virulent B. melitensis; vaccination of IL-17−/− mice resulted in the protection of the lungs, but not the spleen. These data demonstrate the efficacy of mucosal vaccine administration for the generation of protective memory T cells against wt B. melitensis.https://www.frontiersin.org/articles/10.3389/fimmu.2022.995327/fullmucosal and systemic immunity to brucellosis BrucellaT cellsIFN-γIL-17vaccinemucosal
spellingShingle Zakia I. Goodwin
Xinghong Yang
Carol Hoffman
David W. Pascual
Live mucosal vaccination stimulates potent protection via varied CD4+ and CD8+ T cell subsets against wild-type Brucella melitensis 16M challenge
Frontiers in Immunology
mucosal and systemic immunity to brucellosis Brucella
T cells
IFN-γ
IL-17
vaccine
mucosal
title Live mucosal vaccination stimulates potent protection via varied CD4+ and CD8+ T cell subsets against wild-type Brucella melitensis 16M challenge
title_full Live mucosal vaccination stimulates potent protection via varied CD4+ and CD8+ T cell subsets against wild-type Brucella melitensis 16M challenge
title_fullStr Live mucosal vaccination stimulates potent protection via varied CD4+ and CD8+ T cell subsets against wild-type Brucella melitensis 16M challenge
title_full_unstemmed Live mucosal vaccination stimulates potent protection via varied CD4+ and CD8+ T cell subsets against wild-type Brucella melitensis 16M challenge
title_short Live mucosal vaccination stimulates potent protection via varied CD4+ and CD8+ T cell subsets against wild-type Brucella melitensis 16M challenge
title_sort live mucosal vaccination stimulates potent protection via varied cd4 and cd8 t cell subsets against wild type brucella melitensis 16m challenge
topic mucosal and systemic immunity to brucellosis Brucella
T cells
IFN-γ
IL-17
vaccine
mucosal
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.995327/full
work_keys_str_mv AT zakiaigoodwin livemucosalvaccinationstimulatespotentprotectionviavariedcd4andcd8tcellsubsetsagainstwildtypebrucellamelitensis16mchallenge
AT xinghongyang livemucosalvaccinationstimulatespotentprotectionviavariedcd4andcd8tcellsubsetsagainstwildtypebrucellamelitensis16mchallenge
AT carolhoffman livemucosalvaccinationstimulatespotentprotectionviavariedcd4andcd8tcellsubsetsagainstwildtypebrucellamelitensis16mchallenge
AT davidwpascual livemucosalvaccinationstimulatespotentprotectionviavariedcd4andcd8tcellsubsetsagainstwildtypebrucellamelitensis16mchallenge